Novo Nordisk has launched a mobile app for hemophilia patients, the drug maker said.
Days after its acquisition of Coagulife, specialty pharmacy provider BioRx has received limited distribution rights to a treatment for a bleeding disorder described as one of the rarest in the world.
Specialty pharmacy provider BioRx has acquired another specialty pharmacy provider based in Minnesota, BioRx said Monday.
BioPlus Specialty Pharmacy has appointed a new person to head its bleeding disorders program, the company said Tuesday.
Patients with bleeding disorders could be eligible for a scholarship from a specialty pharmacy provider that specializes in treating them.
Novo Nordisk has filed for approval of a treatment for a rare genetic bleeding disorder, the Danish drug maker said Wednesday.
The Food and Drug Administration has approved a treatment for a rare bleeding disorder.
The Food and Drug Administration has given orphan drug designation to a treatment for an...
Bayer HealthCare Pharmaceuticals has launched a free mobile application for patients with hemophilia, the drug...
A drug for treating the bleeding disorder von Willebrand disease has become available, manufacturer Octapharma...
Prospective college students living with bleeding disorders have a chance to receive a scholarship from...